167 related articles for article (PubMed ID: 22585465)
21. Cognitive functioning in breast cancer survivors: a controlled comparison.
Jim HS; Donovan KA; Small BJ; Andrykowski MA; Munster PN; Jacobsen PB
Cancer; 2009 Apr; 115(8):1776-83. PubMed ID: 19224550
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
Schultz PN; Klein MJ; Beck ML; Stava C; Sellin RV
J Clin Nurs; 2005 Feb; 14(2):204-11. PubMed ID: 15669929
[TBL] [Abstract][Full Text] [Related]
23. Cognitive problems among breast cancer survivors: loneliness enhances risk.
Jaremka LM; Peng J; Bornstein R; Alfano CM; Andridge RR; Povoski SP; Lipari AM; Agnese DM; Farrar WB; Yee LD; Carson WE; Kiecolt-Glaser JK
Psychooncology; 2014 Dec; 23(12):1356-64. PubMed ID: 24729533
[TBL] [Abstract][Full Text] [Related]
24. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
[TBL] [Abstract][Full Text] [Related]
25. Brief self-report measure of work-related cognitive limitations in breast cancer survivors.
Ottati A; Feuerstein M
J Cancer Surviv; 2013 Jun; 7(2):262-73. PubMed ID: 23552976
[TBL] [Abstract][Full Text] [Related]
26. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.
Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ
J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526
[TBL] [Abstract][Full Text] [Related]
27. Underutilization of mammography in older breast cancer survivors.
Schapira MM; McAuliffe TL; Nattinger AB
Med Care; 2000 Mar; 38(3):281-9. PubMed ID: 10718353
[TBL] [Abstract][Full Text] [Related]
28. Reduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls.
Wang L; Apple AC; Schroeder MP; Ryals AJ; Voss JL; Gitelman D; Sweet JJ; Butt ZA; Cella D; Wagner LI
Cancer; 2016 Jan; 122(2):258-68. PubMed ID: 26484435
[TBL] [Abstract][Full Text] [Related]
29. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors.
Fu MR; Chen CM; Haber J; Guth AA; Axelrod D
Ann Surg Oncol; 2010 Jul; 17(7):1847-53. PubMed ID: 20140528
[TBL] [Abstract][Full Text] [Related]
30. Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis.
Jung MS; Zhang M; Askren MK; Berman MG; Peltier S; Hayes DF; Therrien B; Reuter-Lorenz PA; Cimprich B
Brain Imaging Behav; 2017 Feb; 11(1):86-97. PubMed ID: 26809289
[TBL] [Abstract][Full Text] [Related]
31. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
[TBL] [Abstract][Full Text] [Related]
32. Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment.
Chen X; Li J; Ren J; Hu X; Zhu C; Tian Y; Hu P; Ma H; Yu F; Wang K
Psychooncology; 2014 Oct; 23(10):1165-71. PubMed ID: 24737580
[TBL] [Abstract][Full Text] [Related]
33. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
[TBL] [Abstract][Full Text] [Related]
34. Cognitive and functional outcomes of 5-year subarachnoid haemorrhage survivors: comparison to matched healthy controls.
Chahal N; Barker-Collo S; Feigin V
Neuroepidemiology; 2011; 37(1):31-8. PubMed ID: 21757962
[TBL] [Abstract][Full Text] [Related]
35. Advanced cognitive training for breast cancer survivors: a randomized controlled trial.
Von Ah D; Carpenter JS; Saykin A; Monahan P; Wu J; Yu M; Rebok G; Ball K; Schneider B; Weaver M; Tallman E; Unverzagt F
Breast Cancer Res Treat; 2012 Oct; 135(3):799-809. PubMed ID: 22918524
[TBL] [Abstract][Full Text] [Related]
36. Speed of processing training in middle-aged and older breast cancer survivors (SOAR): results of a randomized controlled pilot.
Meneses K; Benz R; Bail JR; Vo JB; Triebel K; Fazeli P; Frank J; Vance DE
Breast Cancer Res Treat; 2018 Feb; 168(1):259-267. PubMed ID: 29128897
[TBL] [Abstract][Full Text] [Related]
37. Everyday executive function in standard-risk acute lymphoblastic leukemia survivors.
Walsh KS; Paltin I; Gioia GA; Isquith P; Kadan-Lottick NS; Neglia JP; Brouwers P
Child Neuropsychol; 2015; 21(1):78-89. PubMed ID: 24428397
[TBL] [Abstract][Full Text] [Related]
38. Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls.
Phillips KM; Jim HS; Small BJ; Laronga C; Andrykowski MA; Jacobsen PB
Cancer; 2012 Apr; 118(7):1925-32. PubMed ID: 22161750
[TBL] [Abstract][Full Text] [Related]
39. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy.
Ahles TA; Saykin AJ; Noll WW; Furstenberg CT; Guerin S; Cole B; Mott LA
Psychooncology; 2003 Sep; 12(6):612-9. PubMed ID: 12923801
[TBL] [Abstract][Full Text] [Related]
40. Effects of breast cancer treatment on the hormonal and cognitive consequences of acute stress.
Andreano JM; Waisman J; Donley L; Cahill L
Psychooncology; 2012 Oct; 21(10):1091-8. PubMed ID: 21874658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
